ST Jude Hospital INC
ST Jude Hospital INC was paid $382K by Medicaid between Jan 2018 and Sep 2024, across 52 billing codes. Its largest line is A0429, emergency ambulance ride, basic life support — 56% of everything it billed.
BREA, CA 92821
Next to other General Acute Care Hospital providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,778 | $12K | |
| 2019 | 5,593 | $165K | |
| 2020 | 4,042 | $109K | |
| 2021 | 6,762 | $20K | |
| 2022 | 5,625 | $30K | |
| 2023 | 8,613 | $38K | |
| 2024incomplete | 1,372 | $9K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| A0429 | Emergency ambulance ride, basic life supportAmbulance service, basic life support, emergency transport (bls-emergency) | 56% | 1,058 | 652 | $212K |
| 0450 | Emergency room services | 20% | 4,417 | 3,868 | $77K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.0% | 520 | 508 | $19K |
| 0270 | 2.3% | 2,189 | 1,005 | $9K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.2% | 177 | 162 | $8K |
| 0301 | 1.9% | 130 | 40 | $7K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.8% | 1,971 | 1,791 | $7K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 333 | 324 | $6K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 289 | 283 | $4K |
| 0300 | <1% | 80 | 41 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,685 | 3,214 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 2,504 | 2,258 | $2K |
40 more codes
| 0306 | <1% | 57 | $2K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 342 | $2K |
| 0324 | <1% | 34 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 1,368 | $2K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 221 | $2K |
| 83880 | <1% | 492 | $2K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 269 | $2K |
| 84484 | <1% | 1,529 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 539 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 214 | $1K |
| 84145 | <1% | 575 | $969.15 | |
| 83605 | <1% | 890 | $871.30 | |
| 87040 | <1% | 627 | $755.79 | |
| 0305 | <1% | 33 | $740.00 | |
| 81001 | <1% | 1,915 | $425.40 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 37 | $363.73 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,169 | $361.44 |
| 84703 | <1% | 926 | $357.35 | |
| 83690 | <1% | 1,054 | $352.54 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $317.56 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 26 | $313.68 |
| 0240U | <1% | 13 | $285.26 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 132 | $256.55 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 73 | $220.52 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 109 | $169.94 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 141 | $163.26 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 203 | $150.00 |
| J3490 | Unclassified drugs | <1% | 2,782 | $128.75 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 58 | $101.68 |
| 85610 | <1% | 715 | $100.11 | |
| 85379 | <1% | 14 | $32.56 | |
| 85730 | <1% | 370 | $24.11 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 12 | $4.94 |
| 0250 | 0% | 48 | $0.00 | |
| 99283 | Emergency room visit (moderate) | 0% | 1,095 | $0.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 159 | $0.00 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 947 | $0.00 |
| 81003 | 0% | 191 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 26 | $0.00 |
| 85380 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.